Clinical trials
FAPI clinical trials
Below are recruiting fapi clinical trials, each written for real people, not researchers. We’re tracking 114 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07217704RecruitingPhase 3
New PET scan to find stomach or esophageal cancer spread
This trial tests a new PET scan drug (18F-FAPI) to see if it can better detect where stomach or esophageal cancer has spread. It may help doctors plan the right treatment for you.
Cerritos, CaliforniaAges 18 years+ - NCT07217717RecruitingPhase 3
New PET scan for pancreatic cancer staging
This study tests a new type of PET scan that uses a radioactive tracer called FAPI-74 to find cancer spread in people with pancreatic cancer. The goal is to see if this scan can help doctors better plan treatment.
Cerritos, CaliforniaAges 18 years+ - NCT07215182RecruitingPhase 2
New PET scan method for advanced melanoma
This trial tests a new type of PET scan that may find cancer more clearly and quickly than current scans. It's for people with advanced melanoma that has spread and cannot be removed by surgery.
Herlev, Capital RegionAges 18 years+ - NCT06355427RecruitingPhase 2/Phase 3
New PET scan for bile duct cancer before surgery
This trial tests a new type of PET-CT scan (called FAPI) to see if it helps doctors better decide treatment for people with bile duct cancer that can be surgically removed. It may help avoid unnecessary surgery if the scan shows the cancer has spread.
AmsterdamAges 18 years+ - NCT06916338Recruiting
PET imaging study using 18F-FAPI-04 for breast cancer
This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.
Qingdao, ShandongAges 18–75 - NCT07135128RecruitingPhase 1
Study of a radioactive drug for advanced solid tumors
This trial tests a new radioactive drug (225Ac-FAPI-XT) for people with advanced solid tumors that have stopped responding to standard treatments. It targets a protein called FAP found on many cancer cells, which may help deliver radiation directly to the tumor.
Jinan, ShandongAges 18 years+ - NCT07132645RecruitingEarly Phase 1
New scan for high-grade neuroendocrine cancer
This trial tests a new type of PET/CT scan called [68Ga]Ga-FAPI-04 to see if it can better detect high-grade neuroendocrine tumors. It is for patients whose standard scans show low uptake or who have aggressive tumor features.
Ann Arbor, MichiganAges 18 years+ - NCT07119294Recruiting
FAPI PET/MR imaging for glioblastoma
This study uses a special PET/MR scan to look at certain cells called cancer-associated fibroblasts in glioblastoma brain tumors. It aims to see if this imaging approach can better detect tumors or their recurrence, helping guide treatment decisions.
BrusselsAges 18 years+ - NCT07109440Recruiting
FAPI PET/CT scan for colorectal cancer liver spread
This study uses a special type of PET/CT scan (FAPI) to get a better look at the environment around colorectal cancer that has spread to the liver. It may help doctors learn more about the tumor and plan treatment.
BrusselsAges 18 years+ - NCT07098598RecruitingPhase 2/Phase 3
Using FAPI-PET to diagnose pancreatic cancer
This trial uses a special imaging scan called FAPI-PET to help doctors better diagnose pancreatic cancer. If you are suspected of having pancreatic cancer or a recurrence, this study may help confirm or clarify your diagnosis.
TurkuAges 18–85 - NCT07104058Recruiting
FAPI PET scan to predict relapse in IgG4-RD
This study tests whether a special PET scan (FAPI PET/CT) can detect tiny signs of disease activity (MRD) in people with stable IgG4-RD, and whether it helps predict who might relapse.
Beijing, Beijing MunicipalityAges 18–75 - NCT07077213Recruiting
PET scan test for TB-related lung scarring
This study uses a special PET scan (called FAPI-74) to see if it can detect fibrosis (scarring) in the lungs of people with active TB. It looks at the scan both at the start of treatment and after 6 months of therapy to understand how the lungs heal.
Cincinnati, OhioAges 18 years+ - NCT07083011RecruitingPhase 2
PET scan study for heart failure and cardiac sarcoidosis
This study uses a special PET scan (68Ga-FAPI) to look at inflammation in the heart. It may help researchers understand heart failure and cardiac sarcoidosis better.
Rochester, MinnesotaAges 18 years+ - NCT07062523RecruitingPhase 1/Phase 2
FAPI PET scan for Sjögren's syndrome inflammation
This study uses a special PET scan (FAPI PET) to look at inflammation in people with Sjögren's syndrome. It helps doctors understand how active the disease is. You may join if you have Sjögren's syndrome or a solid tumor that needs this scan, and you are not on certain medications.
BeijingAges 18–80 - NCT05034146Recruiting
Ga-FAPI PET/CT scan for people with cancer
This study tests how useful a special PET/CT scan (called 68Ga-FAPI) is for people who may have or have been diagnosed with cancer. The scan may help doctors see cancer activity more clearly.
Wuhan, HubeiAges 18–88 - NCT06940427RecruitingPhase 2
Testing a new PET scan for lung scarring
This trial is testing a new type of PET scan (FAPI PET) to help doctors see if lung scarring (fibrosis) is getting worse or getting better. It may help decide if a treatment change is needed.
Madison, WisconsinAges 18 years+ - NCT06794372RecruitingPhase 2
68Ga-FAPI-46 PET scan for head and neck cancer staging
This trial tests a new type of PET scan that uses a special tracer (68Ga-FAPI-46) to see if it can better show the extent of head and neck cancers before surgery. It may help doctors plan your treatment more accurately.
Lausanne, Canton of VaudAges 18 years+ - NCT05442151Recruiting
Scan to see cancer-fighting cells using a special PET tracer
This trial tests a PET scan (a type of imaging) that targets cells in the body that help support cancers. It may help doctors better see where cancer-associated cells are located, which could guide future cancer care.
Suita, OsakaAges Any age - NCT05873777Recruiting
PET/CT scans to compare two tracers in FAP or SSTR2-positive cancer
This study compares two special PET/CT scan tracers—68Ga-FAPI-LM3 and 18F-FDG—to see how well they detect cancer that shows FAP or SSTR2 signals. It may help doctors choose better imaging to find or assess certain tumors.
Xiamen, FujianAges 18 years+ - NCT06675357RecruitingPhase 2
FAPI PET/MRI scan for prostate cancer
This trial uses a new type of PET/MRI scan (called FAPI) to see how well it can find prostate cancer. It may help doctors learn about a different way to image the cancer. You can join if you already have a scheduled or recent PSMA PET scan.
Madison, WisconsinAges 18 years+ - NCT06540872RecruitingPhase 2
Testing New PET/MRI Scan in Large DCIS
This study tests a new imaging method that combines a special PET scan (FAPI) with MRI to see if it can better find hidden invasive cancer in people with large areas of ductal carcinoma in situ (DCIS). It aims to improve surgical planning and avoid second surgeries.
Essen, North Rhine-WestphaliaAges 18 years+ - NCT06503146RecruitingPhase 2
New imaging tracer for detecting various cancers
This trial tests a new imaging agent, [18F]FAPI-74, which might help detect certain cancers more clearly. The scan looks for a protein called fibroblast activation protein (FAP) that is often found in tumors. If you have one of the listed cancers and are about to start treatment, this study could help doctors see where the cancer is and how it responds to therapy.
Bethesda, MarylandAges 18–120 - NCT06421142Recruiting
FAPI and FDG scans for bladder cancer
This trial is testing if two types of PET/MRI scans (one using FAPI tracer, another using FDG tracer) are better at finding and evaluating muscle-invasive bladder cancer. It may help doctors decide the best treatment for you.
Fuzhou, FujianAges 18–80 - NCT06413355RecruitingPhase 1
FAPI-74 PET scan for adults with fibrosis
This study tests a new type of PET/CT scan (FAPI-74) to see if it can detect areas of scarring (fibrosis) in the body. It may help doctors better understand and monitor conditions like certain cancers, infections after transplants, and heart inflammation.
Philadelphia, PennsylvaniaAges 21 years+
Hear when a new FAPI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for fapi?
- Yes. Clin2 currently lists 114 recruiting fapi studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a fapi trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a fapi trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.